期刊文献+

曲美他嗪治疗缺血性心肌病40例疗效观察 被引量:5

下载PDF
导出
摘要 目的观察曲美他嗪治疗缺血性心肌病的临床疗效。方法选择2006年1月至2010年1月我科收治的缺血性心肌病患者共76例,随机分为两组:对照组36例,观察组40例。用6min步行试验(6MWT)、超声心动图(UCG)评价曲美他嗪辅助治疗缺血性心肌病的疗效。结果观察组治疗前后自身比较:除左室射血分数(LVEF)以外,6min步行距离(6MWD)、左室收缩末期容积指数(LVES-VI)、左室舒张末期容积指数(LVEDVI)差异均有统计学意义;治疗后的组间比较示曲美他嗪进一步提高缺血性心肌病患者的6MWD,降低LVESVI,无不良反应出现。结论曲美他嗪可减轻心肌缺血,减少耗氧量,对心脏有保护作用,可作为治疗缺血性心肌病的常规联用药物。
作者 程明照
出处 《中国实用医药》 2011年第10期163-164,共2页 China Practical Medicine
  • 相关文献

参考文献6

二级参考文献11

  • 1[1]WHO/IFSC Task Force.Report of 1995 WHO/ISFC task on the defenition and classification of diomyopathies[J].Circulation,1996,93:841-842.
  • 2[2]Momoyama,Mitamura H,Kimura M.ECG differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction[J].J Electrocardiol,1995,28:231-236.
  • 3Mody FV, Singh BN, Mohiuddin IH, et al. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluaion by positron emission tomography. Am J Cardiol. 1998,82(5A) :42K ~ 49K.
  • 4Cahalin LP, Mathier MA, Semigran MJ, at al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure[J] .Chest. 1996,110(2) :325 - 331.
  • 5Peeters P, Mets T.The 6-minute walk as an appropriate exercise test in elderly patents with chronic heart failure[J] .J Gerontol A Biol Sci Med Sci. 1996,51(4) :M147 - M151.
  • 6Ferrari R.Metabolic treatment of myocardial ischaemia. Eur Heart J.1999,20:1144 - 1145.
  • 7Wolff AA,Rotmensch HH,Stanley WC,et al. Metabolic aooroaches to the treatment of ischemic heart disease:the clinicians' perspective. Heart Fail Rev.2002,7(2): 187 - 203.
  • 8Sambandam N, Lopaschuk GD, Brownsey RW, at al. Energy metabolism in the hypertrophied heart. Heart Fail Rev.2002,7(2): 161 - 173.
  • 9Opasich C, Piuna GD, Mazza A, et al. Six-minute walking performance in patients with moderate-to-severe heat failure; is it a usefu indicator in clinical practice? Eur Heart J.2001,22(6) :488 - 496.
  • 10刘兰英,杨琨,朱振宇,刘玉川,余细勇,银巍,汤建,马涧泉,顾军.胚胎干细胞体外分化为心肌细胞诱导因素的探讨[J].中国病理生理杂志,2000,16(5):389-392. 被引量:17

共引文献25

同被引文献35

  • 1王鸣和,王骏.缺血性心肌病的研究近况[J].国际心血管病杂志,2007,34(1):1-5. 被引量:28
  • 2Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxi- dation by inhibiting mitoehondrial long-chain 3-ketoacyl coenzyme A thi- olase [J]. Circ Res,2000,86(5) :580-588.
  • 3Di Napoli P,Taccardi AA, Barsotti A. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in pa- tients with ischaemic dilated cardiomyopathy[J]. Heart ,2005,91 (2) : 161- 165.
  • 4Lloyd-Jones D, Adams R J, Brown TM, et al. Heart diseae and stroke statistics-2010 update: a report from the American Heart Association[J]. Circulation, 2010, 121(7):e46 - e215.
  • 5Schultz HD, Marcus NJ. Heart failure and carotid body chemoreeeption[J]. Adv Exp Med BioI, 2012, 758(2):387-395.
  • 6Zhang L, Lu Y, Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis [J]. J Am Coll Cardiol, 2012, 59(10):913-922.
  • 7Wolff AA,Rotmensch HH,StanleyWC. Metabolic approaches to the treatment of ischemic heart disease:the clinicians perspective[J].Heart Failure Reviews,2002,(02):187-203.
  • 8Ciapponi A,Pizarro R,Harrion J. Trimetazidine for stable angina[J].Cochrane Database of Systematic Reviews,2005,(04):3614.
  • 9DiNapoli P,Taccardi AA,Bardotti A. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardioyopathy[J].Heart,2005,(02):161-165.
  • 10Fragasso G,Perseghin G,De Cobelli F. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients-with heart failure[J].European Heart Journal,2006,(08):942-948.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部